APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Long-acting Reversible Contraceptives (LARCs)

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Long-acting Reversible Contraceptives (LARCs) Industry Growth and Trends Forecast to 2032

Report ID 17442606034 July 2026110 pages

Choose your research edition.

Industry ResearchLong-acting Reversible Contraceptives (LARCs) Industry Research Report 2026138 pages · $2,950 USDIndustry Growth & TrendsGlobal Long-acting Reversible Contraceptives (LARCs) Industry Growth and Trends Forecast to 2032110 pages · $3,450 USDMarket StructureGlobal Long-acting Reversible Contraceptives (LARCs) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Long-acting Reversible Contraceptives (LARCs) Market Outlook and Growth Opportunities 2026208 pages · $4,250 USDMarket Analysis & ForecastGlobal Long-acting Reversible Contraceptives (LARCs) Market Analysis and Forecast 2026-2032202 pages · $4,950 USD

Market perspective

The global Long-acting Reversible Contraceptives (LARCs) market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Long-acting Reversible Contraceptives (LARCs) is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Long-acting Reversible Contraceptives (LARCs) is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Long-acting Reversible Contraceptives (LARCs) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Long-acting Reversible Contraceptives (LARCs) include AbbVie Allergan, ASPIVIX, Cooper Companies, Durbin, H & J Medical, HRA Pharma, Laboratoire 7 MED, Laboratoire CCD and OCON, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Long-acting Reversible Contraceptives (LARCs) market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Long-acting Reversible Contraceptives (LARCs) market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Long-acting Reversible Contraceptives (LARCs) market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Long-acting Reversible Contraceptives (LARCs).

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Long-acting Reversible Contraceptives (LARCs) market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Long-acting Reversible Contraceptives (LARCs) Market by Company

AbbVie Allergan

ASPIVIX

Cooper Companies

Durbin

H & J Medical

HRA Pharma

Laboratoire 7 MED

Laboratoire CCD

OCON

Pregna

Prosan

Shanghai Dahua Pharmaceuticals

Williams Medical Supplies

Yantai JiShengYaoXie

Bayer

Merck

Long-acting Reversible Contraceptives (LARCs) Segment by Type

Copper Intrauterine Devices

Hormonal Intrauterine Devices

Contraceptive Implants

Others

Long-acting Reversible Contraceptives (LARCs) Segment by Application

Age 20-24

Age 25-34

Age 35-44

Others

Long-acting Reversible Contraceptives (LARCs) Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Long-acting Reversible Contraceptives (LARCs) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Long-acting Reversible Contraceptives (LARCs) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Long-acting Reversible Contraceptives (LARCs).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Long-acting Reversible Contraceptives (LARCs) manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Long-acting Reversible Contraceptives (LARCs) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Copper Intrauterine Devices Table 2. Major Company of Hormonal Intrauterine Devices Table 3. Major Company of Contraceptive Implants Table 4. Major Company of Others Table 5. Global Long-acting Reversible Contraceptives (LARCs) Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 6. Global Long-acting Reversible Contraceptives (LARCs) Sales by Type (2021-2026) & (k units) Table 7. Global Long-acting Reversible Contraceptives (LARCs) Sales Market Share in Volume by Type (2021-2026) Table 8. Global Long-acting Reversible Contraceptives (LARCs) Sales by Type (2021-2026) & (US$ Million) Table 9. Global Long-acting Reversible Contraceptives (LARCs) Sales Market Share in Value by Type (2021-2026) Table 10. Global Long-acting Reversible Contraceptives (LARCs) Price by Type (2021-2026) & (USD/unit) Table 11. Global Long-acting Reversible Contraceptives (LARCs) Sales by Type (2027-2032) & (k units) Table 12. Global Long-acting Reversible Contraceptives (LARCs) Sales Market Share in Volume by Type (2027-2032) Table 13. Global Long-acting Reversible Contraceptives (LARCs) Sales by Type (2027-2032) & (US$ Million) Table 14. Global Long-acting Reversible Contraceptives (LARCs) Sales Market Share in Value by Type (2027-2032) Table 15. Global Long-acting Reversible Contraceptives (LARCs) Price by Type (2027-2032) & (USD/unit) Table 16. North America Long-acting Reversible Contraceptives (LARCs) Sales by Type (2021-2026) & (k units) Table 17. North America Long-acting Reversible Contraceptives (LARCs) Sales by Type (2021-2026) & (US$ Million) Table 18. Europe Long-acting Reversible Contraceptives (LARCs) Sales by Type (2021-2026) & (k units) Table 19. Europe Long-acting Reversible Contraceptives (LARCs) Sales by Type (2021-2026) & (US$ Million) Table 20. Asia-Pacific Long-acting Reversible Contraceptives (LARCs) Sales by Type (2021-2026) & (k units) Table 21. Asia-Pacific Long-acting Reversible Contraceptives (LARCs) Sales by Type (2021-2026) & (US$ Million) Table 22. Latin America Long-acting Reversible Contraceptives (LARCs) Sales by Type (2021-2026) & (k units) Table 23. Latin America Long-acting Reversible Contraceptives (LARCs) Sales by Type (2021-2026) & (US$ Million) Table 24. Middle East and Africa Long-acting Reversible Contraceptives (LARCs) Sales by Type (2021-2026) & (k units) Table 25. Middle East and Africa Long-acting Reversible Contraceptives (LARCs) Sales by Type (2021-2026) & (US$ Million) Table 26. Long-acting Reversible Contraceptives (LARCs) Industry Trends Table 27. Long-acting Reversible Contraceptives (LARCs) Industry Drivers Table 28. Long-acting Reversible Contraceptives (LARCs) Industry Opportunities and Challenges Table 29. Long-acting Reversible Contraceptives (LARCs) Industry Restraints Table 30. Global Long-acting Reversible Contraceptives (LARCs) Sales Revenue by Company (US$ Million) & (2021-2026) Table 31. Global Long-acting Reversible Contraceptives (LARCs) Revenue Market Share by Company (2021-2026) Table 32. Global Long-acting Reversible Contraceptives (LARCs) Sales by Company (2021-2026) & (k units) Table 33. Global Long-acting Reversible Contraceptives (LARCs) Sales Share by Company (2021-2026) Table 34. Global Long-acting Reversible Contraceptives (LARCs) Market Price by Company (2021-2026) & (USD/unit) Table 35. Global Long-acting Reversible Contraceptives (LARCs) Industry Company Ranking, 2024 VS 2025 VS 2026 Table 36. Global Long-acting Reversible Contraceptives (LARCs) Major Company Production Sites and Headquarters Table 37. Global Long-acting Reversible Contraceptives (LARCs) Company, Product Type & Application Table 38. Global Long-acting Reversible Contraceptives (LARCs) Company Establishment Date Table 39. Global Company Market Concentration Ratio (CR5 and HHI) Table 40. Global Long-acting Reversible Contraceptives (LARCs) by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 41. Global Long-acting Reversible Contraceptives (LARCs) Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 42. Global Long-acting Reversible Contraceptives (LARCs) Sales by Region (2021-2026) & (k units) Table 43. Global Long-acting Reversible Contraceptives (LARCs) Sales Market Share in Volume by Region (2021-2026) Table 44. Global Long-acting Reversible Contraceptives (LARCs) Sales by Region (2021-2026) & (US$ Million) Table 45. Global Long-acting Reversible Contraceptives (LARCs) Sales Market Share in Value by Region (2021-2026) Table 46. Global Long-acting Reversible Contraceptives (LARCs) Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 47. Global Long-acting Reversible Contraceptives (LARCs) Sales by Region (2027-2032) & (k units) Table 48. Global Long-acting Reversible Contraceptives (LARCs) Sales Market Share in Volume by Region (2027-2032) Table 49. Global Long-acting Reversible Contraceptives (LARCs) Sales by Region (2027-2032) & (US$ Million) Table 50. Global Long-acting Reversible Contraceptives (LARCs) Sales Market Share in Value by Region (2027-2032) Table 51. Global Long-acting Reversible Contraceptives (LARCs) Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2027-2032) Table 52. Global Long-acting Reversible Contraceptives (LARCs) Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 53. Global Long-acting Reversible Contraceptives (LARCs) Sales by Application (2021-2026) & (k units) Table 54. Global Long-acting Reversible Contraceptives (LARCs) Sales Market Share in Volume by Application (2021-2026) Table 55. Global Long-acting Reversible Contraceptives (LARCs) Sales by Application (2021-2026) & (US$ Million) Table 56. Global Long-acting Reversible Contraceptives (LARCs) Sales Market Share in Value by Application (2021-2026) Table 57. Global Long-acting Reversible Contraceptives (LARCs) Price by Application (2021-2026) & (USD/unit) Table 58. Global Long-acting Reversible Contraceptives (LARCs) Sales by Application (2027-2032) & (k units) Table 59. Global Long-acting Reversible Contraceptives (LARCs) Sales Market Share in Volume by Application (2027-2032) Table 60. Global Long-acting Reversible Contraceptives (LARCs) Sales by Application (2027-2032) & (US$ Million) Table 61. Global Long-acting Reversible Contraceptives (LARCs) Sales Market Share in Value by Application (2027-2032) Table 62. Global Long-acting Reversible Contraceptives (LARCs) Price by Application (2027-2032) & (USD/unit) Table 63. North America Long-acting Reversible Contraceptives (LARCs) Sales by Application (2021-2026) & (k units) Table 64. North America Long-acting Reversible Contraceptives (LARCs) Sales by Application (2021-2026) & (US$ Million) Table 65. Europe Long-acting Reversible Contraceptives (LARCs) Sales by Application (2021-2026) & (k units) Table 66. Europe Long-acting Reversible Contraceptives (LARCs) Sales by Application (2021-2026) & (US$ Million) Table 67. Asia-Pacific Long-acting Reversible Contraceptives (LARCs) Sales by Application (2021-2026) & (k units) Table 68. Asia-Pacific Long-acting Reversible Contraceptives (LARCs) Sales by Application (2021-2026) & (US$ Million) Table 69. Latin America Long-acting Reversible Contraceptives (LARCs) Sales by Application (2021-2026) & (k units) Table 70. Latin America Long-acting Reversible Contraceptives (LARCs) Sales by Application (2021-2026) & (US$ Million) Table 71. Middle East and Africa Long-acting Reversible Contraceptives (LARCs) Sales by Application (2021-2026) & (k units) Table 72. Middle East and Africa Long-acting Reversible Contraceptives (LARCs) Sales by Application (2021-2026) & (US$ Million) Table 73. AbbVie Allergan Company Information Table 74. AbbVie Allergan Business Overview Table 75. AbbVie Allergan Long-acting Reversible Contraceptives (LARCs) Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 76. AbbVie Allergan Long-acting Reversible Contraceptives (LARCs) Product Portfolio Table 77. AbbVie Allergan Recent Development Table 78. ASPIVIX Company Information Table 79. ASPIVIX Business Overview Table 80. ASPIVIX Long-acting Reversible Contraceptives (LARCs) Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 81. ASPIVIX Long-acting Reversible Contraceptives (LARCs) Product Portfolio Table 82. ASPIVIX Recent Development Table 83. Cooper Companies Company Information Table 84. Cooper Companies Business Overview Table 85. Cooper Companies Long-acting Reversible Contraceptives (LARCs) Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 86. Cooper Companies Long-acting Reversible Contraceptives (LARCs) Product Portfolio Table 87. Cooper Companies Recent Development Table 88. Durbin Company Information Table 89. Durbin Business Overview Table 90. Durbin Long-acting Reversible Contraceptives (LARCs) Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 91. Durbin Long-acting Reversible Contraceptives (LARCs) Product Portfolio Table 92. Durbin Recent Development Table 93. H & J Medical Company Information Table 94. H & J Medical Business Overview Table 95. H & J Medical Long-acting Reversible Contraceptives (LARCs) Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 96. H & J Medical Long-acting Reversible Contraceptives (LARCs) Product Portfolio Table 97. H & J Medical Recent Development Table 98. HRA Pharma Company Information Table 99. HRA Pharma Business Overview Table 100. HRA Pharma Long-acting Reversible Contraceptives (LARCs) Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 101. HRA Pharma Long-acting Reversible Contraceptives (LARCs) Product Portfolio Table 102. HRA Pharma Recent Development Table 103. Laboratoire 7 MED Company Information Table 104. Laboratoire 7 MED Business Overview Table 105. Laboratoire 7 MED Long-acting Reversible Contraceptives (LARCs) Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 106. Laboratoire 7 MED Long-acting Reversible Contraceptives (LARCs) Product Portfolio Table 107. Laboratoire 7 MED Recent Development Table 108. Laboratoire CCD Company Information Table 109. Laboratoire CCD Business Overview Table 110. Laboratoire CCD Long-acting Reversible Contraceptives (LARCs) Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 111. Laboratoire CCD Long-acting Reversible Contraceptives (LARCs) Product Portfolio Table 112. Laboratoire CCD Recent Development Table 113. OCON Company Information Table 114. OCON Business Overview Table 115. OCON Long-acting Reversible Contraceptives (LARCs) Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 116. OCON Long-acting Reversible Contraceptives (LARCs) Product Portfolio Table 117. OCON Recent Development Table 118. Pregna Company Information Table 119. Pregna Business Overview Table 120. Pregna Long-acting Reversible Contraceptives (LARCs) Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 121. Pregna Long-acting Reversible Contraceptives (LARCs) Product Portfolio Table 122. Pregna Recent Development Table 123. Prosan Company Information Table 124. Prosan Business Overview Table 125. Prosan Long-acting Reversible Contraceptives (LARCs) Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 126. Prosan Long-acting Reversible Contraceptives (LARCs) Product Portfolio Table 127. Prosan Recent Development Table 128. Shanghai Dahua Pharmaceuticals Company Information Table 129. Shanghai Dahua Pharmaceuticals Business Overview Table 130. Shanghai Dahua Pharmaceuticals Long-acting Reversible Contraceptives (LARCs) Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 131. Shanghai Dahua Pharmaceuticals Long-acting Reversible Contraceptives (LARCs) Product Portfolio Table 132. Shanghai Dahua Pharmaceuticals Recent Development Table 133. Williams Medical Supplies Company Information Table 134. Williams Medical Supplies Business Overview Table 135. Williams Medical Supplies Long-acting Reversible Contraceptives (LARCs) Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 136. Williams Medical Supplies Long-acting Reversible Contraceptives (LARCs) Product Portfolio Table 137. Williams Medical Supplies Recent Development Table 138. Yantai JiShengYaoXie Company Information Table 139. Yantai JiShengYaoXie Business Overview Table 140. Yantai JiShengYaoXie Long-acting Reversible Contraceptives (LARCs) Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 141. Yantai JiShengYaoXie Long-acting Reversible Contraceptives (LARCs) Product Portfolio Table 142. Yantai JiShengYaoXie Recent Development Table 143. Bayer Company Information Table 144. Bayer Business Overview Table 145. Bayer Long-acting Reversible Contraceptives (LARCs) Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 146. Bayer Long-acting Reversible Contraceptives (LARCs) Product Portfolio Table 147. Bayer Recent Development Table 148. Merck Company Information Table 149. Merck Business Overview Table 150. Merck Long-acting Reversible Contraceptives (LARCs) Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 151. Merck Long-acting Reversible Contraceptives (LARCs) Product Portfolio Table 152. Merck Recent Development Table 153. North America Long-acting Reversible Contraceptives (LARCs) Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 154. North America Long-acting Reversible Contraceptives (LARCs) Sales by Country (2021-2026) & (k units) Table 155. North America Long-acting Reversible Contraceptives (LARCs) Sales Market Share by Country (2021-2026) Table 156. North America Long-acting Reversible Contraceptives (LARCs) Sales Forecast by Country (2027-2032) & (k units) Table 157. North America Long-acting Reversible Contraceptives (LARCs) Sales Market Share Forecast by Country (2027-2032) Table 158. North America Long-acting Reversible Contraceptives (LARCs) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 159. North America Long-acting Reversible Contraceptives (LARCs) Market Size by Country (2021-2026) & (US$ Million) Table 160. North America Long-acting Reversible Contraceptives (LARCs) Market Share by Country (2021-2026) Table 161. North America Long-acting Reversible Contraceptives (LARCs) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 162. North America Long-acting Reversible Contraceptives (LARCs) Market Share Forecast by Country (2027-2032) Table 163. Europe Long-acting Reversible Contraceptives (LARCs) Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 164. Europe Long-acting Reversible Contraceptives (LARCs) Sales by Country (2021-2026) & (k units) Table 165. Europe Long-acting Reversible Contraceptives (LARCs) Sales Market Share by Country (2021-2026) Table 166. Europe Long-acting Reversible Contraceptives (LARCs) Sales Forecast by Country (2027-2032) & (k units) Table 167. Europe Long-acting Reversible Contraceptives (LARCs) Sales Market Share Forecast by Country (2027-2032) Table 168. Europe Long-acting Reversible Contraceptives (LARCs) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 169. Europe Long-acting Reversible Contraceptives (LARCs) Market Size by Country (2021-2026) & (US$ Million) Table 170. Europe Long-acting Reversible Contraceptives (LARCs) Market Share by Country (2021-2026) Table 171. Europe Long-acting Reversible Contraceptives (LARCs) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 172. Europe Long-acting Reversible Contraceptives (LARCs) Market Share Forecast by Country (2027-2032) Table 173. Asia-Pacific Long-acting Reversible Contraceptives (LARCs) Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 174. Asia-Pacific Long-acting Reversible Contraceptives (LARCs) Sales by Country (2021-2026) & (k units) Table 175. Asia-Pacific Long-acting Reversible Contraceptives (LARCs) Sales Market Share by Country (2021-2026) Table 176. Asia-Pacific Long-acting Reversible Contraceptives (LARCs) Sales Forecast by Country (2027-2032) & (k units) Table 177. Asia-Pacific Long-acting Reversible Contraceptives (LARCs) Sales Market Share Forecast by Country (2027-2032) Table 178. Asia-Pacific Long-acting Reversible Contraceptives (LARCs) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 179. Asia-Pacific Long-acting Reversible Contraceptives (LARCs) Market Size by Country (2021-2026) & (US$ Million) Table 180. Asia-Pacific Long-acting Reversible Contraceptives (LARCs) Market Share by Country (2021-2026) Table 181. Asia-Pacific Long-acting Reversible Contraceptives (LARCs) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 182. Asia-Pacific Long-acting Reversible Contraceptives (LARCs) Market Share Forecast by Country (2027-2032) Table 183. Latin America Long-acting Reversible Contraceptives (LARCs) Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 184. Latin America Long-acting Reversible Contraceptives (LARCs) Sales by Country (2021-2026) & (k units) Table 185. Latin America Long-acting Reversible Contraceptives (LARCs) Sales Market Share by Country (2021-2026) Table 186. Latin America Long-acting Reversible Contraceptives (LARCs) Sales Forecast by Country (2027-2032) & (k units) Table 187. Latin America Long-acting Reversible Contraceptives (LARCs) Sales Market Share Forecast by Country (2027-2032) Table 188. Latin America Long-acting Reversible Contraceptives (LARCs) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 189. Latin America Long-acting Reversible Contraceptives (LARCs) Market Size by Country (2021-2026) & (US$ Million) Table 190. Latin America Long-acting Reversible Contraceptives (LARCs) Market Share by Country (2021-2026) Table 191. Latin America Long-acting Reversible Contraceptives (LARCs) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 192. Latin America Long-acting Reversible Contraceptives (LARCs) Market Share Forecast by Country (2027-2032) Table 193. Middle East and Africa Long-acting Reversible Contraceptives (LARCs) Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 194. Middle East and Africa Long-acting Reversible Contraceptives (LARCs) Sales by Country (2021-2026) & (k units) Table 195. Middle East and Africa Long-acting Reversible Contraceptives (LARCs) Sales Market Share by Country (2021-2026) Table 196. Middle East and Africa Long-acting Reversible Contraceptives (LARCs) Sales Forecast by Country (2027-2032) & (k units) Table 197. Middle East and Africa Long-acting Reversible Contraceptives (LARCs) Sales Market Share Forecast by Country (2027-2032) Table 198. Middle East and Africa Long-acting Reversible Contraceptives (LARCs) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 199. Middle East and Africa Long-acting Reversible Contraceptives (LARCs) Market Size by Country (2021-2026) & (US$ Million) Table 200. Middle East and Africa Long-acting Reversible Contraceptives (LARCs) Market Share by Country (2021-2026) Table 201. Middle East and Africa Long-acting Reversible Contraceptives (LARCs) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 202. Middle East and Africa Long-acting Reversible Contraceptives (LARCs) Market Share Forecast by Country (2027-2032) Table 203. Key Raw Materials Table 204. Raw Materials Key Suppliers Table 205. Long-acting Reversible Contraceptives (LARCs) Distributors List Table 206. Long-acting Reversible Contraceptives (LARCs) Customers List Table 207. Research Programs/Design for This Report Table 208. Authors List of This Report Table 209. Secondary Sources Table 210. Primary Sources List of Figures Figure 1. Long-acting Reversible Contraceptives (LARCs) Image Figure 2. Global Long-acting Reversible Contraceptives (LARCs) Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Long-acting Reversible Contraceptives (LARCs) Market Size (2021-2032) & (US$ Million) Figure 4. Global Long-acting Reversible Contraceptives (LARCs) Sales (2021-2032) & (k units) Figure 5. Copper Intrauterine Devices Image Figure 6. Global Copper Intrauterine Devices Sales YoY Growth (2021-2032) & (k units) Figure 7. Hormonal Intrauterine Devices Image Figure 8. Global Hormonal Intrauterine Devices Sales YoY Growth (2021-2032) & (k units) Figure 9. Contraceptive Implants Image Figure 10. Global Contraceptive Implants Sales YoY Growth (2021-2032) & (k units) Figure 11. Others Image Figure 12. Global Others Sales YoY Growth (2021-2032) & (k units) Figure 13. Global Long-acting Reversible Contraceptives (LARCs) Market Size Overview by Type (2021-2032) & (US$ Million) Figure 14. Global Long-acting Reversible Contraceptives (LARCs) Market Share by Type 2025 VS 2032 Figure 15. North America Long-acting Reversible Contraceptives (LARCs) Sales Market Share in Volume by Type in 2025 Figure 16. North America Long-acting Reversible Contraceptives (LARCs) Sales Market Share in Value by Type in 2025 Figure 17. Europe Long-acting Reversible Contraceptives (LARCs) Sales Market Share in Volume by Type in 2025 Figure 18. Europe Long-acting Reversible Contraceptives (LARCs) Sales Market Share in Value by Type in 2025 Figure 19. Asia-Pacific Long-acting Reversible Contraceptives (LARCs) Sales Market Share in Volume by Type in 2025 Figure 20. Asia-Pacific Long-acting Reversible Contraceptives (LARCs) Sales Market Share in Value by Type in 2025 Figure 21. Latin America Long-acting Reversible Contraceptives (LARCs) Sales Market Share in Volume by Type in 2025 Figure 22. Latin America Long-acting Reversible Contraceptives (LARCs) Sales Market Share in Value by Type in 2025 Figure 23. Middle East and Africa Long-acting Reversible Contraceptives (LARCs) Sales Market Share in Volume by Type in 2025 Figure 24. Middle East and Africa Long-acting Reversible Contraceptives (LARCs) Sales Market Share in Value by Type in 2025 Figure 25. Global Top 5 and 10 Long-acting Reversible Contraceptives (LARCs) Players Market Share by Revenue in 2025 Figure 26. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Age 20-24 Image Figure 28. Global Age 20-24 Sales YoY Growth (2021-2032) & (k units) Figure 29. Age 25-34 Image Figure 30. Global Age 25-34 Sales YoY Growth (2021-2032) & (k units) Figure 31. Age 35-44 Image Figure 32. Global Age 35-44 Sales YoY Growth (2021-2032) & (k units) Figure 33. Others Image Figure 34. Global Others Sales YoY Growth (2021-2032) & (k units) Figure 35. Global Long-acting Reversible Contraceptives (LARCs) Market Size Overview by Application (2021-2032) & (US$ Million) Figure 36. Global Long-acting Reversible Contraceptives (LARCs) Market Share by Application 2025 VS 2032 Figure 37. North America Long-acting Reversible Contraceptives (LARCs) Sales Market Share in Volume by Application in 2025 Figure 38. North America Long-acting Reversible Contraceptives (LARCs) Sales Market Share in Value by Application in 2025 Figure 39. Europe Long-acting Reversible Contraceptives (LARCs) Sales Market Share in Volume by Application in 2025 Figure 40. Europe Long-acting Reversible Contraceptives (LARCs) Sales Market Share in Value by Application in 2025 Figure 41. Asia-Pacific Long-acting Reversible Contraceptives (LARCs) Sales Market Share in Volume by Application in 2025 Figure 42. Asia-Pacific Long-acting Reversible Contraceptives (LARCs) Sales Market Share in Value by Application in 2025 Figure 43. Latin America Long-acting Reversible Contraceptives (LARCs) Sales Market Share in Volume by Application in 2025 Figure 44. Latin America Long-acting Reversible Contraceptives (LARCs) Sales Market Share in Value by Application in 2025 Figure 45. Middle East and Africa Long-acting Reversible Contraceptives (LARCs) Sales Market Share in Volume by Application in 2025 Figure 46. Middle East and Africa Long-acting Reversible Contraceptives (LARCs) Sales Market Share in Value by Application in 2025 Figure 47. North America Long-acting Reversible Contraceptives (LARCs) Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 48. North America Long-acting Reversible Contraceptives (LARCs) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. North America Long-acting Reversible Contraceptives (LARCs) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. North America Long-acting Reversible Contraceptives (LARCs) Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Long-acting Reversible Contraceptives (LARCs) Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 52. Europe Long-acting Reversible Contraceptives (LARCs) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe Long-acting Reversible Contraceptives (LARCs) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Europe Long-acting Reversible Contraceptives (LARCs) Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Long-acting Reversible Contraceptives (LARCs) Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 56. Asia-Pacific Long-acting Reversible Contraceptives (LARCs) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Asia-Pacific Long-acting Reversible Contraceptives (LARCs) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Asia-Pacific Long-acting Reversible Contraceptives (LARCs) Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Long-acting Reversible Contraceptives (LARCs) Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 60. Latin America Long-acting Reversible Contraceptives (LARCs) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Latin America Long-acting Reversible Contraceptives (LARCs) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Latin America Long-acting Reversible Contraceptives (LARCs) Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Long-acting Reversible Contraceptives (LARCs) Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 64. Middle East and Africa Long-acting Reversible Contraceptives (LARCs) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 65. Middle East and Africa Long-acting Reversible Contraceptives (LARCs) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 66. Middle East and Africa Long-acting Reversible Contraceptives (LARCs) Market Share by Country: 2021 VS 2025 VS 2032 Figure 67. Long-acting Reversible Contraceptives (LARCs) Value Chain Figure 68. Key Raw Materials Price Figure 69. Manufacturing Cost Structure Figure 70. Long-acting Reversible Contraceptives (LARCs) Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Copper Intrauterine Devices
  • Hormonal Intrauterine Devices
  • Contraceptive Implants
  • Others
Applications
  • Age 20-24
  • Age 25-34
  • Age 35-44
  • Others
Companies covered
  • AbbVie Allergan
  • ASPIVIX
  • Cooper Companies
  • Durbin
  • H & J Medical
  • HRA Pharma
  • Laboratoire 7 MED
  • Laboratoire CCD
  • OCON
  • Pregna
  • Prosan
  • Shanghai Dahua Pharmaceuticals
  • Williams Medical Supplies
  • Yantai JiShengYaoXie
  • Bayer
  • Merck

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Long-acting Reversible Contraceptives (LARCs) Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Long-acting Reversible Contraceptives (LARCs) Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Long-acting Reversible Contraceptives (LARCs) Market by Type
  6. 1.3.1 Copper Intrauterine Devices
  7. 1.3.2 Hormonal Intrauterine Devices
  8. 1.3.3 Contraceptive Implants
  9. 1.3.4 Others
  10. 1.4 Global Long-acting Reversible Contraceptives (LARCs) Market Size by Type
  11. 1.4.1 Global Long-acting Reversible Contraceptives (LARCs) Market Size Overview by Type (2021-2032)
  12. 1.4.2 Global Long-acting Reversible Contraceptives (LARCs) Historic Market Size Review by Type (2021-2026)
  13. 1.4.3 Global Long-acting Reversible Contraceptives (LARCs) Forecasted Market Size by Type (2027-2032)
  14. 1.5 Key Regions Market Size by Type
  15. 1.5.1 North America Long-acting Reversible Contraceptives (LARCs) Sales Breakdown by Type (2021-2026)
  16. 1.5.2 Europe Long-acting Reversible Contraceptives (LARCs) Sales Breakdown by Type (2021-2026)
  17. 1.5.3 Asia-Pacific Long-acting Reversible Contraceptives (LARCs) Sales Breakdown by Type (2021-2026)
  18. 1.5.4 South America Long-acting Reversible Contraceptives (LARCs) Sales Breakdown by Type (2021-2026)
  19. 1.5.5 Middle East and Africa Long-acting Reversible Contraceptives (LARCs) Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Long-acting Reversible Contraceptives (LARCs) Industry Trends
  2. 2.2 Long-acting Reversible Contraceptives (LARCs) Industry Drivers
  3. 2.3 Long-acting Reversible Contraceptives (LARCs) Industry Opportunities and Challenges
  4. 2.4 Long-acting Reversible Contraceptives (LARCs) Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Long-acting Reversible Contraceptives (LARCs) Revenue (2021-2026)
  2. 3.2 Global Top Players by Long-acting Reversible Contraceptives (LARCs) Sales (2021-2026)
  3. 3.3 Global Top Players by Long-acting Reversible Contraceptives (LARCs) Price (2021-2026)
  4. 3.4 Global Long-acting Reversible Contraceptives (LARCs) Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Long-acting Reversible Contraceptives (LARCs) Major Company Production Sites & Headquarters
  6. 3.6 Global Long-acting Reversible Contraceptives (LARCs) Company, Product Type & Application
  7. 3.7 Global Long-acting Reversible Contraceptives (LARCs) Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Long-acting Reversible Contraceptives (LARCs) Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Long-acting Reversible Contraceptives (LARCs) Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Long-acting Reversible Contraceptives (LARCs) Tier 1, Tier 2, and Tier 3
4 Long-acting Reversible Contraceptives (LARCs) Regional Status and Outlook
  1. 4.1 Global Long-acting Reversible Contraceptives (LARCs) Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Long-acting Reversible Contraceptives (LARCs) Historic Market Size by Region
  3. 4.2.1 Global Long-acting Reversible Contraceptives (LARCs) Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Long-acting Reversible Contraceptives (LARCs) Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Long-acting Reversible Contraceptives (LARCs) Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Long-acting Reversible Contraceptives (LARCs) Forecasted Market Size by Region
  7. 4.3.1 Global Long-acting Reversible Contraceptives (LARCs) Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Long-acting Reversible Contraceptives (LARCs) Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Long-acting Reversible Contraceptives (LARCs) Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Long-acting Reversible Contraceptives (LARCs) by Application
  1. 5.1 Long-acting Reversible Contraceptives (LARCs) Market by Application
  2. 5.1.1 Age 20-24
  3. 5.1.2 Age 25-34
  4. 5.1.3 Age 35-44
  5. 5.1.4 Others
  6. 5.2 Global Long-acting Reversible Contraceptives (LARCs) Market Size by Application
  7. 5.2.1 Global Long-acting Reversible Contraceptives (LARCs) Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global Long-acting Reversible Contraceptives (LARCs) Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global Long-acting Reversible Contraceptives (LARCs) Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America Long-acting Reversible Contraceptives (LARCs) Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe Long-acting Reversible Contraceptives (LARCs) Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific Long-acting Reversible Contraceptives (LARCs) Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America Long-acting Reversible Contraceptives (LARCs) Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa Long-acting Reversible Contraceptives (LARCs) Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 AbbVie Allergan
  2. 6.1.1 AbbVie Allergan Company Information
  3. 6.1.2 AbbVie Allergan Business Overview
  4. 6.1.3 AbbVie Allergan Long-acting Reversible Contraceptives (LARCs) Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 AbbVie Allergan Long-acting Reversible Contraceptives (LARCs) Product Portfolio
  6. 6.1.5 AbbVie Allergan Recent Developments
  7. 6.2 ASPIVIX
  8. 6.2.1 ASPIVIX Company Information
  9. 6.2.2 ASPIVIX Business Overview
  10. 6.2.3 ASPIVIX Long-acting Reversible Contraceptives (LARCs) Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 ASPIVIX Long-acting Reversible Contraceptives (LARCs) Product Portfolio
  12. 6.2.5 ASPIVIX Recent Developments
  13. 6.3 Cooper Companies
  14. 6.3.1 Cooper Companies Company Information
  15. 6.3.2 Cooper Companies Business Overview
  16. 6.3.3 Cooper Companies Long-acting Reversible Contraceptives (LARCs) Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Cooper Companies Long-acting Reversible Contraceptives (LARCs) Product Portfolio
  18. 6.3.5 Cooper Companies Recent Developments
  19. 6.4 Durbin
  20. 6.4.1 Durbin Company Information
  21. 6.4.2 Durbin Business Overview
  22. 6.4.3 Durbin Long-acting Reversible Contraceptives (LARCs) Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Durbin Long-acting Reversible Contraceptives (LARCs) Product Portfolio
  24. 6.4.5 Durbin Recent Developments
  25. 6.5 H & J Medical
  26. 6.5.1 H & J Medical Company Information
  27. 6.5.2 H & J Medical Business Overview
  28. 6.5.3 H & J Medical Long-acting Reversible Contraceptives (LARCs) Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 H & J Medical Long-acting Reversible Contraceptives (LARCs) Product Portfolio
  30. 6.5.5 H & J Medical Recent Developments
  31. 6.6 HRA Pharma
  32. 6.6.1 HRA Pharma Company Information
  33. 6.6.2 HRA Pharma Business Overview
  34. 6.6.3 HRA Pharma Long-acting Reversible Contraceptives (LARCs) Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 HRA Pharma Long-acting Reversible Contraceptives (LARCs) Product Portfolio
  36. 6.6.5 HRA Pharma Recent Developments
  37. 6.7 Laboratoire 7 MED
  38. 6.7.1 Laboratoire 7 MED Company Information
  39. 6.7.2 Laboratoire 7 MED Business Overview
  40. 6.7.3 Laboratoire 7 MED Long-acting Reversible Contraceptives (LARCs) Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Laboratoire 7 MED Long-acting Reversible Contraceptives (LARCs) Product Portfolio
  42. 6.7.5 Laboratoire 7 MED Recent Developments
  43. 6.8 Laboratoire CCD
  44. 6.8.1 Laboratoire CCD Company Information
  45. 6.8.2 Laboratoire CCD Business Overview
  46. 6.8.3 Laboratoire CCD Long-acting Reversible Contraceptives (LARCs) Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Laboratoire CCD Long-acting Reversible Contraceptives (LARCs) Product Portfolio
  48. 6.8.5 Laboratoire CCD Recent Developments
  49. 6.9 OCON
  50. 6.9.1 OCON Company Information
  51. 6.9.2 OCON Business Overview
  52. 6.9.3 OCON Long-acting Reversible Contraceptives (LARCs) Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 OCON Long-acting Reversible Contraceptives (LARCs) Product Portfolio
  54. 6.9.5 OCON Recent Developments
  55. 6.10 Pregna
  56. 6.10.1 Pregna Company Information
  57. 6.10.2 Pregna Business Overview
  58. 6.10.3 Pregna Long-acting Reversible Contraceptives (LARCs) Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Pregna Long-acting Reversible Contraceptives (LARCs) Product Portfolio
  60. 6.10.5 Pregna Recent Developments
  61. 6.11 Prosan
  62. 6.11.1 Prosan Company Information
  63. 6.11.2 Prosan Business Overview
  64. 6.11.3 Prosan Long-acting Reversible Contraceptives (LARCs) Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Prosan Long-acting Reversible Contraceptives (LARCs) Product Portfolio
  66. 6.11.5 Prosan Recent Developments
  67. 6.12 Shanghai Dahua Pharmaceuticals
  68. 6.12.1 Shanghai Dahua Pharmaceuticals Company Information
  69. 6.12.2 Shanghai Dahua Pharmaceuticals Business Overview
  70. 6.12.3 Shanghai Dahua Pharmaceuticals Long-acting Reversible Contraceptives (LARCs) Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Shanghai Dahua Pharmaceuticals Long-acting Reversible Contraceptives (LARCs) Product Portfolio
  72. 6.12.5 Shanghai Dahua Pharmaceuticals Recent Developments
  73. 6.13 Williams Medical Supplies
  74. 6.13.1 Williams Medical Supplies Company Information
  75. 6.13.2 Williams Medical Supplies Business Overview
  76. 6.13.3 Williams Medical Supplies Long-acting Reversible Contraceptives (LARCs) Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Williams Medical Supplies Long-acting Reversible Contraceptives (LARCs) Product Portfolio
  78. 6.13.5 Williams Medical Supplies Recent Developments
  79. 6.14 Yantai JiShengYaoXie
  80. 6.14.1 Yantai JiShengYaoXie Company Information
  81. 6.14.2 Yantai JiShengYaoXie Business Overview
  82. 6.14.3 Yantai JiShengYaoXie Long-acting Reversible Contraceptives (LARCs) Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Yantai JiShengYaoXie Long-acting Reversible Contraceptives (LARCs) Product Portfolio
  84. 6.14.5 Yantai JiShengYaoXie Recent Developments
  85. 6.15 Bayer
  86. 6.15.1 Bayer Company Information
  87. 6.15.2 Bayer Business Overview
  88. 6.15.3 Bayer Long-acting Reversible Contraceptives (LARCs) Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 Bayer Long-acting Reversible Contraceptives (LARCs) Product Portfolio
  90. 6.15.5 Bayer Recent Developments
  91. 6.16 Merck
  92. 6.16.1 Merck Company Information
  93. 6.16.2 Merck Business Overview
  94. 6.16.3 Merck Long-acting Reversible Contraceptives (LARCs) Sales, Revenue and Gross Margin (2021-2026)
  95. 6.16.4 Merck Long-acting Reversible Contraceptives (LARCs) Product Portfolio
  96. 6.16.5 Merck Recent Developments
7 North America by Country
  1. 7.1 North America Long-acting Reversible Contraceptives (LARCs) Sales by Country
  2. 7.1.1 North America Long-acting Reversible Contraceptives (LARCs) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Long-acting Reversible Contraceptives (LARCs) Sales by Country (2021-2026)
  4. 7.1.3 North America Long-acting Reversible Contraceptives (LARCs) Sales Forecast by Country (2027-2032)
  5. 7.2 North America Long-acting Reversible Contraceptives (LARCs) Market Size by Country
  6. 7.2.1 North America Long-acting Reversible Contraceptives (LARCs) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Long-acting Reversible Contraceptives (LARCs) Market Size by Country (2021-2026)
  8. 7.2.3 North America Long-acting Reversible Contraceptives (LARCs) Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Long-acting Reversible Contraceptives (LARCs) Sales by Country
  2. 8.1.1 Europe Long-acting Reversible Contraceptives (LARCs) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Long-acting Reversible Contraceptives (LARCs) Sales by Country (2021-2026)
  4. 8.1.3 Europe Long-acting Reversible Contraceptives (LARCs) Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Long-acting Reversible Contraceptives (LARCs) Market Size by Country
  6. 8.2.1 Europe Long-acting Reversible Contraceptives (LARCs) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Long-acting Reversible Contraceptives (LARCs) Market Size by Country (2021-2026)
  8. 8.2.3 Europe Long-acting Reversible Contraceptives (LARCs) Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Long-acting Reversible Contraceptives (LARCs) Sales by Country
  2. 9.1.1 Asia-Pacific Long-acting Reversible Contraceptives (LARCs) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Long-acting Reversible Contraceptives (LARCs) Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Long-acting Reversible Contraceptives (LARCs) Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Long-acting Reversible Contraceptives (LARCs) Market Size by Country
  6. 9.2.1 Asia-Pacific Long-acting Reversible Contraceptives (LARCs) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Long-acting Reversible Contraceptives (LARCs) Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Long-acting Reversible Contraceptives (LARCs) Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Long-acting Reversible Contraceptives (LARCs) Sales by Country
  2. 10.1.1 South America Long-acting Reversible Contraceptives (LARCs) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Long-acting Reversible Contraceptives (LARCs) Sales by Country (2021-2026)
  4. 10.1.3 South America Long-acting Reversible Contraceptives (LARCs) Sales Forecast by Country (2027-2032)
  5. 10.2 South America Long-acting Reversible Contraceptives (LARCs) Market Size by Country
  6. 10.2.1 South America Long-acting Reversible Contraceptives (LARCs) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Long-acting Reversible Contraceptives (LARCs) Market Size by Country (2021-2026)
  8. 10.2.3 South America Long-acting Reversible Contraceptives (LARCs) Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Long-acting Reversible Contraceptives (LARCs) Sales by Country
  2. 11.1.1 Middle East and Africa Long-acting Reversible Contraceptives (LARCs) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Long-acting Reversible Contraceptives (LARCs) Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Long-acting Reversible Contraceptives (LARCs) Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Long-acting Reversible Contraceptives (LARCs) Market Size by Country
  6. 11.2.1 Middle East and Africa Long-acting Reversible Contraceptives (LARCs) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Long-acting Reversible Contraceptives (LARCs) Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Long-acting Reversible Contraceptives (LARCs) Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Long-acting Reversible Contraceptives (LARCs) Value Chain Analysis
  2. 12.1.1 Long-acting Reversible Contraceptives (LARCs) Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Long-acting Reversible Contraceptives (LARCs) Production Mode & Process
  7. 12.2 Long-acting Reversible Contraceptives (LARCs) Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Long-acting Reversible Contraceptives (LARCs) Distributors
  10. 12.2.3 Long-acting Reversible Contraceptives (LARCs) Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst